CardioFocus(R) Announces European CE Mark Approval Of The Next-Generation HeartLight(R) Excalibur Balloon(TM) Designed For The Treatment Of Atrial Fibrillation

MARLBOROUGH, Mass., Sept. 27, 2017 -- (Healthcare Sales & Marketing Network) -- CardioFocus, Inc. today announced the European CE Mark approval of the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of atrial fibrilla... Devices, Interventional, Cardiology, Regulatory CardioFocus, HeartLight, Excalibur Balloon, Atrial Fibrillation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news